Literature DB >> 15894804

Translocation of dynorphin neuropeptides across the plasma membrane. A putative mechanism of signal transmission.

Zoya Marinova1, Vladana Vukojevic, Slavina Surcheva, Tatiana Yakovleva, Gvido Cebers, Natalia Pasikova, Ivan Usynin, Loïc Hugonin, Weijie Fang, Mathias Hallberg, Daniel Hirschberg, Tomas Bergman, Ulo Langel, Kurt F Hauser, Aladdin Pramanik, Jane V Aldrich, Astrid Gräslund, Lars Terenius, Georgy Bakalkin.   

Abstract

Several peptides, including penetratin and Tat, are known to translocate across the plasma membrane. Dynorphin opioid peptides are similar to cell-penetrating peptides in a high content of basic and hydrophobic amino acid residues. We demonstrate that dynorphin A and big dynorphin, consisting of dynorphins A and B, can penetrate into neurons and non-neuronal cells using confocal fluorescence microscopy/immunolabeling. The peptide distribution was characterized by cytoplasmic labeling with minimal signal in the cell nucleus and on the plasma membrane. Translocated peptides were associated with the endoplasmic reticulum but not with the Golgi apparatus or clathrin-coated endocytotic vesicles. Rapid entry of dynorphin A into the cytoplasm of live cells was revealed by fluorescence correlation spectroscopy. The translocation potential of dynorphin A was comparable with that of transportan-10, a prototypical cell-penetrating peptide. A central big dynorphin fragment, which retains all basic amino acids, and dynorphin B did not enter the cells. The latter two peptides interacted with negatively charged phospholipid vesicles similarly to big dynorphin and dynorphin A, suggesting that interactions of these peptides with phospholipids in the plasma membrane are not impaired. Translocation was not mediated via opioid receptors. The potential of dynorphins to penetrate into cells correlates with their ability to induce non-opioid effects in animals. Translocation across the plasma membrane may represent a previously unknown mechanism by which dynorphins can signal information to the cell interior.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15894804     DOI: 10.1074/jbc.M412494200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Prodynorphin mutations cause the neurodegenerative disorder spinocerebellar ataxia type 23.

Authors:  Georgy Bakalkin; Hiroyuki Watanabe; Justyna Jezierska; Cloë Depoorter; Corien Verschuuren-Bemelmans; Igor Bazov; Konstantin A Artemenko; Tatjana Yakovleva; Dennis Dooijes; Bart P C Van de Warrenburg; Roman A Zubarev; Berry Kremer; Pamela E Knapp; Kurt F Hauser; Cisca Wijmenga; Fred Nyberg; Richard J Sinke; Dineke S Verbeek
Journal:  Am J Hum Genet       Date:  2010-10-28       Impact factor: 11.025

Review 2.  30 years of dynorphins--new insights on their functions in neuropsychiatric diseases.

Authors:  Christoph Schwarzer
Journal:  Pharmacol Ther       Date:  2009-05-28       Impact factor: 12.310

Review 3.  Endogenous Opioids at the Intersection of Opioid Addiction, Pain, and Depression: The Search for a Precision Medicine Approach.

Authors:  Michael A Emery; Huda Akil
Journal:  Annu Rev Neurosci       Date:  2020-02-28       Impact factor: 12.449

Review 4.  Dynorphins in Development and Disease: Implications for Cardiovascular Disease.

Authors:  Cody Cissom; Jason J Paris; Zia Shariat-Madar
Journal:  Curr Mol Med       Date:  2020       Impact factor: 2.222

5.  Evaluation of an on-capillary copper complexation methodology for the investigation of in vitro metabolism of dynorphin A 1-17.

Authors:  Courtney D Kuhnline; Susan M Lunte
Journal:  J Sep Sci       Date:  2010-08       Impact factor: 3.645

Review 6.  Salvinorin A analogs and other κ-opioid receptor compounds as treatments for cocaine abuse.

Authors:  Bronwyn M Kivell; Amy W M Ewald; Thomas E Prisinzano
Journal:  Adv Pharmacol       Date:  2014

7.  Regulation of the peritoneal macrophage functional activity by the MP-5 and MP-6 myelopeptides under stress.

Authors:  S V Gein; T V Gavrilova; O N Gein; L S Nikitina; M V Chereshneva; V A Chereshnev; E A Kirilina
Journal:  Dokl Biol Sci       Date:  2017-09-01

8.  Solid Phase Synthesis and Application of Labeled Peptide Derivatives: Probes of Receptor-Opioid Peptide Interactions.

Authors:  Jane V Aldrich; Vivek Kumar; Bhaswati Dattachowdhury; Angela M Peck; Xin Wang; Thomas F Murray
Journal:  Int J Pept Res Ther       Date:  2008-12-01       Impact factor: 1.931

9.  Identification and characterization of novel PDYN mutations in dominant cerebellar ataxia cases.

Authors:  Justyna Jezierska; Giovanni Stevanin; Hiroyuki Watanabe; Michiel R Fokkens; Fabien Zagnoli; Jérôme Kok; Jean-Yves Goas; Pierre Bertrand; Christophe Robin; Alexis Brice; Georgy Bakalkin; Alexandra Durr; Dineke S Verbeek
Journal:  J Neurol       Date:  2013-03-08       Impact factor: 4.849

10.  Mechanisms of cellular uptake of cell-penetrating peptides.

Authors:  Fatemeh Madani; Staffan Lindberg; Ulo Langel; Shiroh Futaki; Astrid Gräslund
Journal:  J Biophys       Date:  2011-04-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.